Functional characterization of Foxp3-specific spontaneous immune responses

S K Larsen1, S Munir, A Woetmann

  • 1Center for Cancer Immune Therapy (CCIT), Department of Hematology, 54P4, Copenhagen University Hospital, Herlev, Denmark.

Leukemia
|July 2, 2013
PubMed
Summary

Scientists discovered cytotoxic T cells targeting Foxp3, a protein in regulatory T cells (Tregs). These Foxp3-specific T cells can eliminate Tregs and cancer cells, suggesting potential for cancer immunotherapy by boosting these "suppressor of suppressor" immune responses.